Genetic Addiction Risk Score (GARS(™)) as a Predictor of Substance Use Disorder: Identifying Predisposition Not Diagnosis

Documenti analoghi

• The Benefits of Genetic Addiction Risk Score (GARS(™)) Testing in Substance Use Disorder (SUD)
  di: Blum, Kenneth, et al.
  Pubblicazione: (2018)
• The benefits of genetic addiction risk score (GARS™) and pro-dopamine regulation in combating suicide in the American Indian population
  di: Blum, Kenneth, et al.
  Pubblicazione: (2018)
• Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)
  di: Blum, Kenneth, et al.
  Pubblicazione: (2017)
• Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD)
  di: Blum, K, et al.
  Pubblicazione: (2019)
• Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)?
  di: Blum, K, et al.
  Pubblicazione: (2018)